Critical Reviews in Toxicology | 2021
Application of adverse outcome pathway networks to integrate mechanistic data informing the choice of a point of departure for hydrogen sulfide exposure limits
Abstract
Abstract Acute exposure to hydrogen sulfide initiates a series of hallmark biological effects that occur progressively at increasing exposure levels: odor perception, conjunctivitis, olfactory paralysis, “knockdown,” pulmonary edema, and apnea. Although effects of exposure to high concentrations of hydrogen sulfide are clear, effects associated with chronic, low-level exposure in humans is under debate, leading to uncertainty in the critical effect used in regulatory risk assessments addressing low dose exposures. This study integrates experimental animal, observational epidemiology, and occupational exposure evidence by applying a pathway-based approach. A hypothesized adverse outcome pathway (AOP) network was developed from 34 studies, composed of 4 AOPs sharing 1 molecular initiating events (MIE) and culminating in 4 adverse outcomes. A comparative assessment of effect levels and weight of evidence identified an AOP leading to a biologically-plausible, low-dose outcome relative to the other outcomes (nasal lesions, 30\u2009ppm versus olfactory paralysis, >100\u2009ppm; neurological effects, >80\u2009ppm; pulmonary edema, >80\u2009ppm). This AOP (i.e. AOP1) consists of the following key events: cytochrome oxidase inhibition (>10\u2009ppm), neuronal cell loss (>30\u2009ppm), and olfactory nasal lesions (defined as both neuronal cell loss and basal cell hyperplasia; >30\u2009ppm) in rodents. The key event relationships in this pathway were supported by moderate empirical evidence and have high biological plausibility due to known mechanistic understanding and consistency in observations for diverse chemicals.